| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1007973129 |
| P356 | DOI | 10.1038/ONC.2015.501 |
| P8608 | Fatcat ID | release_gg7444c7uvfxbbwxr7tzlctogy |
| P698 | PubMed publication ID | 26751773 |
| P50 | author | B L Grégoire Nyomba | Q79378110 |
| P2093 | author name string | S R Ande | |
| S Mishra | |||
| K H Nguyen | |||
| G P Padilla-Meier | |||
| P2860 | cites work | Concordance with World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) guidelines for cancer prevention and obesity-related cancer risk in the Framingham Offspring cohort (1991-2008) | Q37336185 |
| The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin-related protein | Q37635432 | ||
| Adipose tissue-resident immune cells: key players in immunometabolism. | Q38026316 | ||
| Adaptive immunity in obesity and insulin resistance | Q38030832 | ||
| SeXX matters in immunity | Q38163200 | ||
| Prohibitin overexpression in adipocytes induces mitochondrial biogenesis, leads to obesity development, and affects glucose homeostasis in a sex-specific manner. | Q38306276 | ||
| Insulin induced phosphorylation of prohibitin at tyrosine 114 recruits Shp1. | Q38353489 | ||
| Immunometabolism: an emerging frontier | Q38876919 | ||
| Lipid metabolism mediated by adipocyte lipid binding protein (ALBP/aP2) gene expression in human THP-1 macrophages | Q40346706 | ||
| Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration | Q40393756 | ||
| ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development | Q42199386 | ||
| A bidirectional crosstalk between iNKT cells and adipocytes mediated by leptin modulates susceptibility for T cell mediated hepatitis | Q42249964 | ||
| Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells | Q42460970 | ||
| Prohibitin has an important role in adipocyte differentiation | Q42802709 | ||
| White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models | Q42826900 | ||
| Prohibitin interacts with phosphatidylinositol 3,4,5-triphosphate (PIP3) and modulates insulin signaling | Q42832815 | ||
| Heterogeneity in a mouse model of histiocytosis: transformation of Langerin+ dendritic cells, macrophages, and precursors. | Q53301956 | ||
| A postmigrational switch among skin-derived dendritic cells to a macrophage-like phenotype is predetermined by the intracutaneous cytokine balance. | Q53619786 | ||
| Obesity and cancer | Q57748968 | ||
| Mild caloric restriction up-regulates the expression of prohibitin: a proteome study | Q83265115 | ||
| The scaffold protein prohibitin is required for antigen-stimulated signaling in mast cells | Q85721263 | ||
| Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells | Q24298483 | ||
| Mechanisms and therapeutic advances in the management of endocrine-resistant breast cancer | Q27001260 | ||
| Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies | Q29614869 | ||
| Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013 | Q29616834 | ||
| Vi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses | Q30448411 | ||
| Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. | Q34139220 | ||
| Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial. | Q34334262 | ||
| DNAJC19, a mitochondrial cochaperone associated with cardiomyopathy, forms a complex with prohibitins to regulate cardiolipin remodeling | Q34421187 | ||
| Elevated GH/IGF-I promotes mammary tumors in high-fat, but not low-fat, fed mice | Q34434910 | ||
| Therapeutic action of ghrelin in a mouse model of colitis. | Q34525422 | ||
| The mitochondrial PHB complex: roles in mitochondrial respiratory complex assembly, ageing and degenerative disease | Q34536917 | ||
| Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer | Q34769124 | ||
| Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation. | Q34944118 | ||
| Impact of obesity on development and progression of mammary tumors in preclinical models of breast cancer | Q34975962 | ||
| Role of inflammation and oxidative stress in post-menopausal oestrogen-dependent breast cancer | Q34998410 | ||
| Prohibitin couples diapause signalling to mitochondrial metabolism during ageing in C. elegans | Q35007074 | ||
| Treatment with insulin analog X10 and IGF-1 increases growth of colon cancer allografts | Q35048673 | ||
| Differences in IGF-axis protein expression and survival among multiethnic breast cancer patients | Q35236778 | ||
| Obesity, adipocytokines, and insulin resistance in breast cancer | Q35831676 | ||
| Obesity and cancer risk: the role of the insulin-IGF axis | Q36587115 | ||
| Ghrelin, obesity and diabetes | Q36950900 | ||
| Adipose-immune interactions during obesity and caloric restriction: reciprocal mechanisms regulating immunity and health span | Q37089841 | ||
| MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity. | Q37100064 | ||
| Insulin receptor phosphorylation by endogenous insulin or the insulin analog AspB10 promotes mammary tumor growth independent of the IGF-I receptor | Q37193406 | ||
| P433 | issue | 34 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obesity | Q12174 |
| insulin resistance | Q1053470 | ||
| P304 | page(s) | 4459-4470 | |
| P577 | publication date | 2016-01-11 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Expression of a mutant prohibitin from the aP2 gene promoter leads to obesity-linked tumor development in insulin resistance-dependent manner | |
| P478 | volume | 35 |
| Q90310096 | A novel c-Kit/phospho-prohibitin axis enhances ovarian cancer stemness and chemoresistance via Notch3-PBX1 and β-catenin-ABCG2 signaling |
| Q50649721 | Characterization of mitochondrial prohibitin from Boleophthalmus pectinirostris and evaluation of its possible role in spermatogenesis. |
| Q58696754 | Gonadectomy in Mito-Ob mice revealed a sex-dimorphic relationship between prohibitin and sex steroids in adipose tissue biology and glucose homeostasis |
| Q60949486 | Obesity-Linked Cancers: Current Knowledge, Challenges and Limitations in Mechanistic Studies and Rodent Models |
| Q38288384 | Prohibitin - At the crossroads of obesity-linked diabetes and cancer. |
| Q47555171 | Prohibitin plays a critical role in Enterovirus 71 neuropathogenesis |
| Q33830554 | Prohibitin-induced obesity leads to anovulation and polycystic ovary in mice |
| Q36719439 | Prohibitin-induced, obesity-associated insulin resistance and accompanying low-grade inflammation causes NASH and HCC |
| Q89700562 | Prohibitin: a potential therapeutic target in tyrosine kinase signaling |
| Q64275992 | Prohibitin: a prime candidate for a pleiotropic effector that mediates sex differences in obesity, insulin resistance, and metabolic dysregulation |
| Q37037962 | Prohibitin: an unexpected role in sex dimorphic functions |
| Q38953433 | Tumour biology of obesity-related cancers: understanding the molecular concept for better diagnosis and treatment. |
| Q91868469 | Twenty Novel Disease Group-Specific and 12 New Shared Macrophage Pathways in Eight Groups of 34 Diseases Including 24 Inflammatory Organ Diseases and 10 Types of Tumors |
Search more.